PCR: EBITDA fell 46% and net profit 79% year-over-year, driven by weak Chlorine Derivatives

About this update from Pcc Rokita Spolka Akcyjna

Revenue and profit declined sharply in the first three quarters of 2024, mainly due to weak performance in Chlorine Derivatives, while Polyurethanes and Energy segments showed resilience. The company maintained strong liquidity, continued major investments, and faces ongoing risks from energy prices, regulation, and global competition.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Pcc Rokita Spolka Akcyjna